ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2025
[Risk Factors and Prognosis of Pneumoconiosis Combined With Bacterial Pneumonia: Application of a Random Forest Model].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Analysis of Factors Affecting Endoscopic Follow-up Compliance in High-Risk Patients With Early Gastrointestinal Cancer].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To apply a random forest model combined with logistic regression in the understudied area of pneumoconiosis complications, and to investigate the incidence and risk factors of pneumoconiosis complicated by bacterial pneumonia, and the effect of concomitant bacterial pneumonia on the survival and prognosis of patients with pneumoconiosis. Methods: Pneumoconiosis patients admitted to the West China Fourth Hospital, Sichuan University, between January 2018 and April 2022 were enrolled and divided into a group of those with only pneumoconiosis and another group of those with pneumoconiosis complicated by bacterial pneumonia. Univariate analyses, including chi-squared test, t-test, or rank sum test, were conducted to examine the differences between the groups. A random forest model was used to screen the variables, and the risk factors of pneumoconiosis complicated by bacterial pneumonia were identified by stepwise forward logistic regression method. Cox regression was applied to the survival data to assess the effect of concomitant bacterial pneumonia on the survival and prognosis of pneumoconiosis patients. Results: Among the 742 pneumoconiosis patients, 536 cases (72.24%) had concomitant bacterial pneumonia. Among the 55 deaths, 36 cases (65.45%) had concomitant bacterial pneumonia. Univariate analysis showed statistically significant differences in age, duration of disease, lung function, duration of exposure, lung lavage, pulmonary tuberculosis, and emphysema between the two groups ( Conclusion: Pneumoconiosis patients are susceptible to bacterial pneumonia and are influenced by multiple risk factors. Concomitant bacterial pneumonia markedly affects the patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.